Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation

Inflammation

Inflammation

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Impact of Age on Treatment Response to Endobronchial Valve Treatment in Patients With Severe Emphysema.

Archivos de bronconeumologia·2026

Same author

Minimal Important Difference of FEV<sub>1</sub> and FVC in COPD Patients Undergoing Bronchoscopic Lung Volume Reduction.

Archivos de bronconeumologia·2026

Same author

Bronchial Thermoplasty Induced Changes in Blood Transcriptome Profile of Patients with Severe Asthma.

International journal of molecular sciences·2026

Same author

Bronchial thermoplasty for severe asthma: Systematic review and meta-analysis of benefits and harms.

The journal of allergy and clinical immunology. Global·2026

Same author

Prevalence of Type 2 Inflammation in Chronic Obstructive Pulmonary Disease Patients With Frequent Exacerbations.

Allergy·2026

Same author

Contact-compression induces inflammatory and remodeling responses in bronchial epithelial cells.

American journal of physiology. Lung cellular and molecular physiology·2026

Search research articles

Related Experiment Video

Updated: Aug 24, 2025

Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations

Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations

Published on: January 10, 2015

The Decrease in Serum sRAGE Levels Upon Smoking is Associated with Activated Neutrophils.

Valerie R Wiersma¹, Susan J M Hoonhorst^2,3, Nick H T Ten Hacken²

¹Department of Hematology, Cancer Research Center Groningen, University Medical Center Groningen, Groningen, The Netherlands.

|October 25, 2022

Summary

This summary is machine-generated.

Cigarette smoking rapidly decreases soluble Receptor for Advanced Glycation End-products (sRAGE) levels by activating neutrophils. This neutrophil activation increases their binding capacity for sRAGE, explaining the biomarker

Keywords:

Biomarkers CD11b COPD Cigarette smoke sRAGE

More Related Videos

Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System

Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System

Published on: October 22, 2020

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

Related Experiment Videos

Last Updated: Aug 24, 2025

Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations

Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations

Published on: January 10, 2015

Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System

Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System

Published on: October 22, 2020

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

Area of Science:

Pulmonary Medicine
Immunology
Biochemistry

Background:

Soluble Receptor for Advanced Glycation End-products (sRAGE) is a potential biomarker for Chronic Obstructive Pulmonary Disease (COPD).
Cigarette smoking significantly reduces circulating sRAGE levels, affecting its utility as a biomarker.

Purpose of the Study:

To investigate the mechanism behind the rapid decrease in serum sRAGE levels following cigarette smoking.
To understand how smoking influences sRAGE levels in the context of COPD biomarker research.

Main Methods:

Monitoring neutrophil activation and CD11b expression in blood after smoking.
In vitro experiments assessing neutrophil capacity to bind sRAGE after activation.

Main Results:

Smoking three cigarettes within an hour significantly increased activated neutrophils in blood within two hours.
Increased expression of the RAGE ligand CD11b was observed on leukocytes post-smoking.
Activated neutrophils in vitro demonstrated an enhanced ability to bind sRAGE.

Conclusions:

Smoking activates neutrophils, leading to increased expression of CD11b, a RAGE ligand.
This neutrophil activation and CD11b upregulation facilitate increased binding and clearance of sRAGE from circulation.
The findings elucidate a key mechanism for smoking-induced sRAGE reduction, impacting COPD biomarker interpretation.